$165.71 USD (0.00% in 24 hours)
Alnylam Pharmaceuticals, Inc.
As of 2026-11-02 07:55 UTC. The Crypto App market data.
Alnylam Pharmaceuticals, Inc. is a leading global biopharmaceutical company at the forefront of developing innovative RNA interference (RNAi) therapeutics. The company pioneered the translation of Nobel Prize-winning science into an entirely new class of innovative medicines. Utilizing its proprietary drug delivery technology platforms, Alnylam is dedicated to the R&D, manufacturing, and commercialization of…